Eli Lilly & Co.’s new weight-loss drug Zepbound is now available at US pharmacies, offering an alternative to rival medications like Novo Nordisk A/S’s Wegovy as supply issues persist.
Zepbound was approved by the US Food and Drug Administration in early November as a treatment for people with obesity. Patients with a prescription from their doctor will now be able to get the drug, which was added to the list of available drugs for Express Scripts and Cigna Healthcare this month, Lilly said in a statement Tuesday.
The Link LonkDecember 05, 2023 at 08:50PM
https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTEyLTA1L3plcGJvdW5kLXdlaWdodC1sb3NzLWRydWctbm93LW9uLXNhbGUtdG8tcml2YWwtaGFyZC10by1maW5kLXdlZ292edIBAA?oc=5
Eli Lilly's New Weight-Loss Drug Now on Sale to Rival Hard-to-Find Wegovy - Bloomberg
https://news.google.com/search?q=hard&hl=en-US&gl=US&ceid=US:en
No comments:
Post a Comment